3). Because other factors in the growth medium may modulate FasL-induced apoptosis signaling, we first confirmed that the sensitizing effect is specifically mediated Dabrafenib by TNFα.

We therefore added TNFα-neutralizing antibodies produced by the V1q hybridoma cell line (100 μL of the culture supernatant) to the primary hepatocytes 30 minutes before TNFα and FasL stimulation. TNFα-neutralizing antibodies effectively prevented the sensitization because caspase-3/caspase-7 activity did not increase beyond that measured with FasL alone (Fig. 2A). We then tested the inverse scenario (i.e., whether FasL was also able to sensitize hepatocytes to TNFα-induced apoptosis). For that purpose, cells were first treated with FasL, and 2 hours later, TNFα was added for a total of 4 hours before the measurement of active caspase-3/caspase-7. selleckchem As demonstrated in Fig. 2B, FasL-induced caspase-3/caspase-7 activity could not be further increased by TNFα. This finding confirms that the apoptosis sensitization effect of TNFα is specific for this cytokine, needs a certain time threshold (as shown in Fig. 1C), and involves a molecular mechanism that cannot be engaged by FasL. To completely exclude the implication of growth factors, we tested the role of fetal bovine serum (FBS) in the sensitization effect. As shown

in Supporting Fig. 4, FBS neither enhanced nor inhibited the sensitization of FasL-induced apoptosis by TNFα, but primary hepatocytes turned out to be more sensitive toward FasL-induced apoptosis in the presence of FBS (see also Walter 上海皓元 et al.12). To uncover the molecular mechanism of the TNFα sensitization, we tested various possibilities for TNFα crosstalk with the Fas/FasL system. First, we compared apoptosis between WT and Fas−/− hepatocytes to investigate the role of Fas. As shown in Fig. 3A, Fas−/− hepatocytes did not show any caspase-3/caspase-7 activation in response to FasL or sensitization by TNFα. In contrast, caspase-3/caspase-7

activity levels were unchanged between WT and Fas−/− cells when they were treated with TNFα/actinomycin D (ActD), and this indicated that TNFα-mediated sensitization to FasL-induced apoptosis required Fas. Therefore, we next tested whether sensitization could be due to up-regulation of endogenous Fas by TNFα. However, the qRT-PCR analysis did not reveal any induction of Fas messenger RNA (mRNA) in response to TNFα (data not shown). Besides Fas, TNFα could up-regulate endogenous FasL and thereby amplify the FasL-induced apoptotic response. To test this hypothesis, we analyzed TNFα sensitization in FasLgld/gld hepatocytes, which express a mutant form of FasL that cannot bind Fas. As shown in Fig. 3B, the loss of endogenous FasL production did not significantly reduce the enhanced caspase-3/caspase-7 activation because of TNFα preincubation of the FasL-treated cells.